Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

Dame Tracey Emin revealed on BBC 100 Women that Elton John was the first person to congratulate her after she was made a dame ...

(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...